16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
W2A22b
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
3D125

PharmaResources (Kaiyuan) Co., Ltd.

  • PharmaResources
About PharmaResources (Kaiyuan) Co., Ltd.

PharmaResources(Kaiyuan) Co., Ltd. takes the development, production and sales of APIs as its main business, and the factory covers an area of 60000 m2 and a construction area of 17800 m2. Pharmaresources mainly produces more than 30 varieties of cardiovascular and cerebrovascular, central nervous system and antiviral. 

Certifications

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Laboratory Services
Contact info

Products from PharmaResources (Kaiyuan) Co., Ltd. (5)

PharmaResources (Kaiyuan) Co., Ltd. Resources (4)

  • News PharmaResources Marketing-CADD Service

    Our Computer-aided Drug Design (CADD) team has standardized procedures and highly-skilled scientists for solving complex problems related to discovery. The CADD team routinely supports discovery projects starting from target identification to lead optimization. We can provide virtual screening, scaffold hopping and de-novo molecule design. We have a wide range of tools available for compound optimization. Also, we have proven expertise in collaborative small molecule, PROTAC and peptide drug discovery projects.
  • Brochure PharmaResources

    PharmaResources is a fast growing CRO/CDMO company based in China, which is a one-stop service provider of small molecules for new drug discovery and manufacturing. Currently we have around 1000 scientists, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.